期刊文献+

参芪抑瘤方联合幽门螺杆菌根治方案对幽门螺杆菌阳性胃癌前病变患者疗效及血清GAS、TRX-1、C-myc蛋白表达影响 被引量:14

Effect of Shenqi Yiliu Decoction Combined with Hp Radical Therapy on the Expression of GAS,TRX-1 and C-myc in Serum of Patients with Hp Positive Precancerous Lesions of Gastric Cancer
下载PDF
导出
摘要 目的研究参芪抑瘤方联合幽门螺杆菌(Hp)根治方案对Hp阳性胃癌前病变(PLGC)患者的治疗效果,以及对血清胃泌素(GAS)、硫氧还蛋白-1(TRX-1)水平和胃黏膜C-myc蛋白表达的影响。方法选择2016年8月-2018年7月期间收治的180例Hp阳性PLGC患者,按照随机数字表法将患者分为对照组和观察组,每组90例。对照组患者接受Hp根治方案治疗:克拉霉素与阿莫西林连续治疗2周,奥美拉唑与枸橼酸铋钾连续治疗12周。观察组在对照组的基础上联合参芪抑瘤方,连续治疗12周。比较两组治疗前后血清中GAS、TRX-1水平、胃黏膜中C-myc蛋白表达、病理组织学评分、中医症候评分、临床功能(PRO)评分和疗效。结果观察组总有效率和Hp消除率为90.00%(81/90)、94.44%(85/90)高于对照组总有效率的76.67%(69/90)、84.44%(76/90),差异有统计学意义(P<0.05);治疗后,观察组血清GAS、TRX-1水平、胃黏膜C-myc蛋白表达均低于对照组,差异有统计学意义(P<0.05);观察组各项中医症候评分、各项PRO量表评分以及病理组织学评分低于对照组,差异有统计学意义(P<0.05)。结论采用参芪抑瘤方联合Hp根治方案治疗Hp阳性PLGC患者,能够显著提高疗效和Hp清除率,并可抑制血清中GAS、TRX-1和胃黏膜中C-myc蛋白的表达,改善患者临床表现和胃黏膜病变情况,值得推广应用。 Objective To study the therapeutic effect of Shenqi Yiliu Decoction combined with HP radical therapy on patients with HP-positive precancerous lesions of gastric cancer(PLGC),as well as the effects of serum gastrin(GAS),thioredoxin-1(TRX-1)levels and C-myc protein expression in gastric mucosa.Methods 180 cases of Hp-positive PLGC patients admitted to our hospital from August 2016 to July 2018 were divided into control group and observation group according to random number table method,90 cases in each group.The control group received HP radical therapy:Clarithromycin and Amoxicillin for 2 weeks,Omeprazole and Bismuth Potassium Citrate for 12 weeks.The observation group was treated with Shenqi Yiliu Decoction for 12 weeks on the basis of the control group.The levels of GAS and TRX-1 in serum,C-myc protein expression in gastric mucosa,histopathological score,TCM syndrome score,clinical function(PRO)score and curative effect were compared between the two groups before and after treatment.Results The total effective rate and the elimination rate of Hp in the observation group were 90.00%(81/90)and 94.44%(85/90)higher than 76.67%(69/90)and 84.44%(76/90)in the control group(P<0.05);After treatment,the levels of serum GAS,TRX-1 and C-myc protein expression in gastric mucosa in the observation group were lower(P<0.05);The scores of TCM symptoms,PRO scale and histopathology in the observation group were lower(P<0.05).Conclusion Shenqi Yiliu Decoction combined with HP radical therapy for Hp-positive PLGC patients can significantly improve the efficacy and clearance rate of Hp,inhibit the expression of GAS,TRX-1 in serum and C-myc protein in gastric mucosa,improve the clinical manifestations of patients and gastric mucosal lesions,which is worthy of popularization and application.
作者 齐姗姗 王旭旭 武纪生 魏玉芳 霍志刚 贾震宇 QI Shanshan;WANG Xuxu;WU Jisheng;WEI Yufang;HUO Zhigang;JIA Zhenyu(Shijiazhuang Hospital of Traditional Chinese Medicine,Shijiazhuang 050000,Hebei,China)
机构地区 石家庄市中医院
出处 《辽宁中医药大学学报》 CAS 2020年第2期194-197,共4页 Journal of Liaoning University of Traditional Chinese Medicine
基金 河北省医学科学研究课题(201801842).
关键词 胃癌前病变 幽门螺杆菌 参芪抑瘤方 胃泌素 硫氧还蛋白-1 C-MYC蛋白 precancerous lesions of gastric cancer helicobacter pylori Shenqi Yiliu Decoction gastrin thioredoxin-1 C-myc protein
  • 相关文献

参考文献19

二级参考文献249

共引文献817

同被引文献258

引证文献14

二级引证文献31

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部